IP Library Granted Patent US 7,595,079
Granted Patent B2
US 7,595,079 · App. 11/177,411 · Granted Sep 29, 2009

Nutritional conjunctive support therapy for recovery in animals following stress or illness

Assignee: Bomac Vets Plus, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,595,079
App. No.
11/177,411
Granted
Sep 29, 2009
Kind
B2
Abstract

A composition of probiotics, vitamins and minerals, electrolytes with glutamine and glucose along with medium chain triglycerides are provided as a supplement to animals. This is administered to cattle, calves, sheep, pigs, horses, dogs, and cats that are experiencing stress and or are undergoing medical drug therapy to treat conditions of diseases along with pre and post operative surgical conditions. The composition helps correct imbalances in beneficial bacteria, provides energy and helps in rehydration to reduce recovery time from stress or in disease treatment in these animals.

Claims (11)

1. A nutritive feed composition having therapeutic effects in an animal for maintaining and enhancing gastrointestinal microflora, the rehydration status, energy balance and the immune system consisting of:

a. probiotics, wherein the probiotics consist of yeast, Lactobacillus species, and Enterococcus species and wherein the probiotics are in an active dose of 10 7 to 10 11 colony forming units (CFU) per day;

b. prebiotics, wherein the prebiotics are selected from the group consisting of inulin or soy fructo-oligosaccharide and wherein the prebiotic is used in the composition from concentrations of about 0.01 to 10% (w/w);

c. glutamine or glutamine analog, wherein the concentration of the glutamine or glutamine analog is from 44 mg to 100 mg grams/kilogram body weight;

d. glucose, wherein the concentration of glucose is from 10 to 50 grams/kilogram of body weight;

e. glycine, wherein the concentration of glycine is 66 mg to 264 mg/kilogram of body weight;

f. electrolytes, wherein the electrolytes are selected from the group consisting of sodium chloride and potassium chloride and wherein the concentration of the electrolytes are from 5 mg to 100 mg/kilogram of body weight;

g. vitamins, wherein the vitamins include vitamin A in a concentration from 50-300 IU/kilogram bodyweight, vitamin E in a concentration of 0.5 IU/kilogram bodyweight, folic acid in a concentration from 0.5 to 2 IU/kilogram bodyweight, and vitamin D 3 in a concentration from 5-30 IU/kilogram bodyweight;

h. minerals, wherein the minerals include zinc in a concentration from 100 mg to 200 mg/kilogram bodyweight, copper in a concentration from 0.1 to 2 mg/kilogram bodyweight, manganese in a concentration from 0.05 to 0.2 mg/kilogram bodyweight;

i. medium chain triglycerides, wherein the concentration of medium chain triglycerides is from 100 mg to 600 mg/kilogram bodyweight and wherein the medium chain triglycerides contain acyl chain lengths from 8 to 10 carbons; and

j. wherein elements a-i are in a unit dosage form in a delivery system and the delivery system is selected from the group consisting of boluses, tablets, chewable tablets, capsules, powders, suspensions, gels, or pastes.

Assignments (3)
SECURITY INTEREST Recorded Mar 31, 2025
From: VETS PLUS, INC.
To: APOGEM CAPITAL LLC, AS AGENT
Reel/Frame 070681/0527 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2021
From: LALL, RAJIV; DUBOURDIEU, DANIEL
To: BOMAC VETS PLUS, INC.
Reel/Frame 057737/0018 →
CHANGE OF NAME Recorded Oct 8, 2021
From: BOMAC VETS PLUS, INC.
To: VETS PLUS, INC.
Reel/Frame 058048/0035 →
Continuity (1)
Related Publication 20070009502A1 · Jan 11, 2007